Research Historical Balance Sheet
RSSS Stock | USD 2.68 0.02 0.75% |
Trend analysis of Research Solutions balance sheet accounts such as Total Stockholder Equity of 14.1 M, Property Plant And Equipment Net of 75.2 K, Current Deferred Revenue of 10.9 M or Accounts Payable of 5.9 M provides information on Research Solutions' total assets, liabilities, and equity, which is the actual value of Research Solutions to its prevalent stockholders. By breaking down trends over time using Research Solutions balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
Financial Statement Analysis is much more than just reviewing and examining Research Solutions latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Research Solutions is a good buy for the upcoming year.
Research Solutions Inventory |
|
Research |
About Research Balance Sheet Analysis
Balance Sheet is a snapshot of the financial position of Research Solutions at a specified time, usually calculated after every quarter, six months, or one year. Research Solutions Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Research Solutions and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Research currently owns. An asset can also be divided into two categories, current and non-current.
Research Solutions Balance Sheet Chart
Add Fundamental
Total Assets
Total assets refers to the total amount of Research Solutions assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Research Solutions books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Total Current Liabilities
Total Current Liabilities is an item on Research Solutions balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Research Solutions are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.Most accounts from Research Solutions' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Research Solutions current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Research Solutions. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. For more information on how to buy Research Stock please use our How to Invest in Research Solutions guide.At this time, Research Solutions' Inventory is comparatively stable compared to the past year. Other Current Assets is likely to gain to about 2.1 M in 2025, whereas Property Plant And Equipment Net is likely to drop slightly above 75.2 K in 2025.
2024 | 2025 (projected) | Short and Long Term Debt Total | 71.4K | 67.8K | Total Assets | 48.1M | 50.5M |
Research Solutions balance sheet Correlations
Click cells to compare fundamentals
Research Solutions Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Research Solutions balance sheet Accounts
2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
Total Assets | 16.9M | 17.0M | 21.8M | 41.9M | 48.1M | 50.5M | |
Other Current Liab | 6.7M | 6.6M | 8.1M | 8.8M | 10.2M | 10.7M | |
Total Current Liabilities | 11.5M | 12.1M | 14.5M | 17.9M | 20.5M | 21.6M | |
Total Stockholder Equity | 5.4M | 4.9M | 7.3M | 11.7M | 13.4M | 14.1M | |
Property Plant And Equipment Net | 20.8K | 48.0K | 70.2K | 88.0K | 79.2K | 75.2K | |
Current Deferred Revenue | 4.8M | 5.5M | 6.4M | 9.0M | 10.4M | 10.9M | |
Net Debt | (11.0M) | (10.6M) | (13.5M) | (6.1M) | (5.5M) | (5.8M) | |
Retained Earnings | (21.5M) | (23.1M) | (22.5M) | (26.3M) | (23.7M) | (22.5M) | |
Accounts Payable | 6.7M | 6.6M | 8.1M | 8.8M | 10.2M | 5.9M | |
Cash | 11.0M | 10.6M | 13.5M | 6.1M | 7.0M | 5.4M | |
Non Current Assets Total | 21.7K | 48.9K | 533.3K | 27.2M | 31.2M | 32.8M | |
Cash And Short Term Investments | 11.0M | 10.6M | 13.5M | 6.1M | 7.0M | 5.7M | |
Net Receivables | 4.7M | 5.3M | 6.2M | 6.9M | 7.9M | 5.4M | |
Common Stock Shares Outstanding | 26.0M | 26.4M | 29.1M | 28.9M | 33.2M | 21.8M | |
Liabilities And Stockholders Equity | 16.9M | 17.0M | 21.8M | 41.9M | 48.1M | 50.5M | |
Other Current Assets | 1.2M | 1.1M | 400.3K | 1.7M | 2.0M | 2.1M | |
Other Stockholder Equity | 27.0M | 28.1M | 29.9M | 38.1M | 43.8M | 46.0M | |
Total Liab | 11.5M | 12.1M | 14.5M | 30.2M | 34.7M | 36.4M | |
Property Plant And Equipment Gross | 20.8K | 889.0K | 952.1K | 1.0M | 1.2M | 603.2K | |
Total Current Assets | 16.9M | 17.0M | 21.3M | 14.7M | 16.9M | 12.0M | |
Accumulated Other Comprehensive Income | (119.6K) | (121.9K) | (118.2K) | (118.8K) | (106.9K) | (112.3K) | |
Short Term Debt | 6.7M | 6.6M | 8.1M | (8.8M) | (10.2M) | (9.7M) | |
Common Stock | 26.5K | 27.1K | 29.5K | 32.3K | 37.1K | 22.9K | |
Non Current Liabilities Total | 3.6M | 4.8M | 5.5M | 12.3M | 14.1M | 14.8M | |
Net Tangible Assets | 4.9M | 5.4M | 4.9M | 6.9M | 7.9M | 8.3M | |
Other Assets | 6.2K | 906.0 | 893.0 | 1.1K | 946.8 | 899.46 | |
Property Plant Equipment | 83.6K | 20.8K | 48.0K | 70.2K | 63.2K | 60.0K | |
Non Currrent Assets Other | 906.0 | 893.0 | 1.1K | 981.0 | 882.9 | 838.76 | |
Net Invested Capital | 5.4M | 4.9M | 7.3M | 11.7M | 13.4M | 14.1M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Research Stock Analysis
When running Research Solutions' price analysis, check to measure Research Solutions' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Research Solutions is operating at the current time. Most of Research Solutions' value examination focuses on studying past and present price action to predict the probability of Research Solutions' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Research Solutions' price. Additionally, you may evaluate how the addition of Research Solutions to your portfolios can decrease your overall portfolio volatility.